Region: Global
Category: Life Sciences

Global Life Sciences

(45,012 reports matching your criteria)
  • Flea and Tick Products

    ... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$7.3 Billion by the ... Read More

  • Hospital Asset Management

    ... at a CAGR of 11.5% over the analysis period 2024-2030. Real time Location Systems (RTLS), one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$10.6 Billion by ... Read More

  • Hospitals and Outpatient Care Centers

    ... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More

  • Minimally Invasive Surgery

    ... at a CAGR of 9.1% over the analysis period 2024-2030. Surgical Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$70.4 Billion by the end of ... Read More

  • Monopolar Electrosurgery Devices

    ... at a CAGR of 4.2% over the analysis period 2024-2030. Hand Instruments, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Rapid Medical Diagnostic Kits

    ... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More

  • Small Bone and Joint Orthopedic Devices

    ... reach US$20.4 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.7% ... Read More

  • Technology Spending on Core Administration in Healthcare

    ... expected to reach US$54.4 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. In-house Solution, one of the segments analyzed in the report, is expected to record a 4.2% CAGR ... Read More

  • Vial Adaptors for Reconstitution Drug

    ... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More

  • Veterinary Ultrasound Scanners

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More

  • Sports Management Software

    ... at a CAGR of 13.2% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$8.2 Billion by the end of ... Read More

  • Brachytherapy

    ... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More

  • Aesthetic Implants

    ... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More

  • Tangential Flow Filtration

    ... at a CAGR of 12.0% over the analysis period 2024-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.0 Billion by the end of ... Read More

  • Semi-Automatic Filling Equipment

    ... at a CAGR of 6.6% over the analysis period 2024-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$2.0 Billion by the ... Read More

  • Vancomycin

    ... 4.9% over the analysis period 2024-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. ... Read More

  • Surgical Lights

    ... CAGR of 5.1% over the analysis period 2024-2030. LED Lights, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.7 Billion by the end of the analysis ... Read More

  • Automated Liquid Handlers

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Serial Dilution Liquid Handlers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$772.8 Million by the ... Read More

  • Urinary Drainage Bags

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Leg Bags, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.8 Billion by the end of ... Read More

  • Potassium Bromide

    ... CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.5 Million While China is Forecast to Grow at 7.8% CAGR The Potassium Bromide market in the U.S. is estimated at ... Read More

  • Venturi Masks

    ... CAGR of 11.5% over the analysis period 2024-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More

  • Cerebral Angiography

    ... CAGR of 6.6% over the analysis period 2024-2030. Magnetic Resonance Angiography Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$36.8 Million by the end of ... Read More

  • Insulin Pens

    ... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More

  • Hydrogel Dressings

    ... CAGR of 7.1% over the analysis period 2024-2030. Amorphous Hydrogel Dressings, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$810.7 Million by the end of the ... Read More

  • Disposable Respirators

    ... CAGR of 4.5% over the analysis period 2024-2030. N-Series Respirators, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings